Protalix BioTherapeutics Inc (PLX)
1.405
+0.16
(+13.31%)
USD |
NYAM |
Nov 14, 16:00
1.40
0.00 (0.00%)
After-Hours: 20:00
Protalix BioTherapeutics Gross Profit (Annual): 42.51M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 42.51M |
December 31, 2022 | 28.05M |
December 31, 2021 | 22.00M |
December 31, 2020 | 52.02M |
December 31, 2019 | 43.80M |
December 31, 2018 | 24.94M |
December 31, 2017 | 5.847M |
December 31, 2016 | 0.801M |
December 31, 2015 | 3.634M |
December 31, 2014 | 2.893M |
December 31, 2013 | 0.00 |
December 31, 2012 | 26.28M |
December 31, 2011 | 1.443M |
Date | Value |
---|---|
December 31, 2010 | 6.861M |
December 31, 2009 | -3.187M |
December 31, 2008 | 0.00 |
December 31, 2007 | |
December 31, 2006 | |
December 31, 2005 | 0.115M |
December 31, 2004 | 0.31M |
December 31, 2003 | |
December 31, 2002 | |
December 31, 2001 | |
December 31, 2000 | |
December 31, 1999 | 0.8712M |
December 31, 1998 | 1.730M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
22.00M
Minimum
2021
52.02M
Maximum
2020
37.68M
Average
42.51M
Median
2023
Gross Profit (Annual) Benchmarks
Accuray Inc | 142.92M |
Aethlon Medical Inc | -- |
Predictive Oncology Inc | 1.145M |
bluebird bio Inc | -4.03M |
AIM ImmunoTech Inc | 0.16M |